e-learning
resources
Munich 2006
Sunday 03.09.2006
COPD – therapy/exacerbations
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Serum uric acid levels among patients with COPD exacerbations
Z. M. Lazic, V. B. Cupurdija, L. A. Novkovic, C. V. Ivan, O. M. Gajovic (Kragujevac, Serbia And Montenegro)
Source:
Annual Congress 2006 - COPD – therapy/exacerbations
Session:
COPD – therapy/exacerbations
Session type:
E-Posters in free access
Number:
308
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Z. M. Lazic, V. B. Cupurdija, L. A. Novkovic, C. V. Ivan, O. M. Gajovic (Kragujevac, Serbia And Montenegro). Serum uric acid levels among patients with COPD exacerbations. Eur Respir J 2006; 28: Suppl. 50, 308
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Serum uric acid levels among COPD patients
Source: Eur Respir J 2003; 22: Suppl. 45, 435s
Year: 2003
Assessment of serum uric acid in COPD exacerbations
Source: International Congress 2017 – Markers of COPD progression
Year: 2017
Serum uric acid and uric acid/creatinine ratio in exacerbations of COPD
Source: Annual Congress 2011 - Monitoring exacerbations of airway diseases
Year: 2011
Serum uric acid as a predictor of mortality and future exacerbations of COPD
Source: Eur Respir J 2014; 43: 43-53
Year: 2004
Serum uric acid levels and uric acid/creatinine ratio in stable COPD patients: Are these parameters efficiently predict risky patients for exacerbation and/or severity of the disease?
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016
Serum ascorbic acid concentration in patients with acute pneumonia and in COPD patients with and without respiratory failure
Source: Eur Respir J 2004; 24: Suppl. 48, 92s
Year: 2004
Does serum uric acid levels predict in-hospital mortality in severe COPD exacerbations?
Source: International Congress 2015 – COPD: interesting notes
Year: 2015
Serum magnesium levels in acute exacerbation of COPD
Source: Annual Congress 2007 - Exacerbations of COPD
Year: 2007
Serum levels of hyaluronic acid are associated with COPD severity and predict survival
Source: Eur Respir J, 53 (3) 1801183; 10.1183/13993003.01183-2018
Year: 2019
Serum ascorbid acid concentration in COPD patients with partial and with complete respiratory failure
Source: Eur Respir J 2001; 18: Suppl. 33, 209s
Year: 2001
Blood plasma levels of ascorbic acid in COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 674s
Year: 2006
Serum lipid levels in patients with bronchiectasis
Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi
Year: 2008
Serum lysophosphatidic acid levels and exacerbation frequency in chronic obstructive pulmonary disease (COPD)
Source: Virtual Congress 2020 – Ageing, metabolic syndrome and the lung
Year: 2020
Increased serum endotoxin levels as biomarker in acute exacerbations of COPD.
Source: International Congress 2018 – Biomarkers of COPD
Year: 2018
Serum interleukin-6 levels correlate with malnutrition in patients with acute exacerbation of COPD
Source: Annual Congress 2009 - Organisation of care for individuals with chronic respiratory disease
Year: 2009
Urinary uric acid excretion and overnight change in the urinary uric acid: creatinin ratio as a marker of tissue hypoxia in patients with COPD and OSA
Source: Eur Respir J 2006; 28: Suppl. 50, 408s
Year: 2006
Total serum bilirubin levels are not related to the severity of COPD
Source: Annual Congress 2011 - COPD mechanisms
Year: 2011
Activin-A levels in sputum and serum of COPD, asthma and ACOS patients during acute exacerbation and at baseline
Source: International Congress 2017 – Infection and exacerbation science
Year: 2017
Serum YKL-40 modulation in severe asthma patients treated with Mepolizumab
Source: Virtual Congress 2020 – Monoclonal antibodies in asthma
Year: 2020
Serum neopterin and IL-6 as biomarkers in patients with COPD.
Source: International Congress 2017 – Novel molecular and genetic targets in COPD
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept